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ABSTRACT

MATERIAL AND METHODS

Summary
Patients suffering from burn-related injuries admitted to the hospital
concurrently using nicotine and/or smoke are believed to be at an increased
risk of poor outcomes and the development of complications following burn
reconstruction, however data varies within the literature and remains
controversial. This systematic review and meta-analysis compared outcomes
and complications from studies during the years 1986 to 2018 between 8568
burn patients admitted to the hospital who use nicotine and/or smoke to
299543 burn patients admitted who do not use nicotine and/or smoke. The
PubMed, EMBASE, Cochrane Library, and Web of Science databases were
systematically and independently searched. Clinical characteristics,
nicotine/smoking use, outcomes and complications were recorded. PRISMA
and Cochrane guidelines where used throughout the review. Five of the 9
studies included in our study, were eligible for meta-analysis, with results
from 7 of the possible 21 outcomes and complications queried. In conclusion,
this systematic review and meta-analysis found that compared to patients
suffering from burn-related injuries who do not use nicotine and/or smoke,
patients using nicotine/smoking were found to have a higher rate of intubation
and more wound/local skin infections.

MATERIAL AND METHODS
Preferred Reporting Items for Systematic Reviews and Meta-Analysis
(PRISMA) guidelines11 were followed throughout the literature search process
to structure the framework for the review.
Search
A medical library informationist (SMS) conducted the initial literature search
using four databases (MEDLINE via PubMed, Embase, Cochrane, and Web of
Science) from inception to December 20, 2018. Reference lists of relevant
articles were hand searched to identify additional relevant studies. All
references were imported into Covidence (Veritas Health Innovation Ltd,
Melbourne, Australia) and reference management software and duplicates
were removed.

Hospital LOS
Four studies evaluated hospital LOS. 17, 19, 24, 27 In two studies, hospital LOS
means ranged from 11.4 to 37 days in 130 patients consuming nicotine or
smoking compared to 16.2 to 37 days in 478 patients not consuming nicotine
or smoking. These results were not significant (SMD: -0.02, 95% CI: -0.22,
0.18, I2 = 0%, p = 0.84).17, 27
Ventilator days
Two studies evaluated the number of days patients were on a ventilator. 17, 19
One study found a mean number of days a patient was on a ventilator of 5.7
days in 14 patients consuming nicotine or smoking compared to 6 days in 14
patients not consuming nicotine or smoking. These results were not significant
(SMD: -0.02, 95% CI: -0.76, 0.72, I2 = Not applicable, p = 0.95). 17

Data Extraction
Two reviewers (KMK and PS) systematically and independently performed the
title screening, followed by abstract screening, and full-article review to ensure
quality and accuracy throughout the process. Any disagreements regarding
studies to be included or excluded were resolved by discussion. If disagreements
were still present after discussion, a third reviewer (CSH) resolved remaining
conflict. The following data were extracted qualitatively and quantitatively for
outcome and complication variables of interest: authors, year of publication,
type of study, sample size, male and female distributions, nicotine/smoking used
on admission to the hospital, burn related operations, graft loss/failure, percent
total body surface area burned (%TBSA), depth of burn (superficial, superficial
partial thickness, deep partial thickness, full thickness), skin grafting,
amputations, length of hospital stay (LOS), time period of wound closure,
inhalation injury, number of days on a ventilator, rate of intubation, intensive
care unit (ICU) LOS, mortality, overall infections, wound/local skin infections,
sepsis, decubitus ulcer (hospital acquired pressure injury), deep vein thrombosis
(DVT)/pulmonary embolism (PE), renal failure, respiratory complications, and
ventilator-associated events. If there were multiple reports from the same study,
one data collection form was completed for the study from all of the reports to
avoid duplicating results.

Intubation
Three studies evaluated rates of intubation. 17, 19, 27 One study was available
that assessed a mean number of patients intubated. A mean of 23 patients
consuming nicotine or smoking was compared to a mean of 21 patients not
consuming nicotine or smoking. (RR: 4.38, 95% CI: 2.51, 7.63, I2 = Not
applicable, p < 0.00001). 27
ICU LOS
Two studies evaluated ICU LOS. 19, 27 One study found a mean ICU LOS of
28.3 days in 116 patients consuming nicotine or smoking compared to 28.4
days in 464 patients not consuming nicotine or smoking. These results were
not significant (SMD: -0.00, 95% CI: -0.21, 0.20, I2 = Not applicable, p =
0.98). 27
Mortality
Five studies evaluated mortality. 7, 17, 19, 21, 27 In four studies, mortality occurred
in 94/388 (24%) patients consuming nicotine or smoking compared to
177/1140 (16%) patients not consuming nicotine or smoking. These results
were not significant (RR: 1.53, 95% CI: 0.36, 6.53, I2 = 96%, p = 0.56). 7, 17, 21,
27 After removing the study Knowlin et al, heterogeneity dropped from I2 =
96% to I2 = 91%, with a p = 0.56 to p = 0.04. 27 No single study could be
identified for the high heterogeneity.7, 17, 21, 27
Wound/local skin infections
One study found 344/8180 (4%) cellulitis infections in patients consuming
nicotine or smoking compared to 3399/129091 (2.6%) cellulitis infections in
patients not consuming nicotine or smoking (RR: 1.44, 95% CI: 1.09, 1.90, I2
= 84%, p = 0.01). 23 No study could be removed to assess heterogeneity.
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RESULTS

%TBSA
Three studies evaluated %TBSA. 17, 24, 27 In two studies, means ranged from
4% to 12% TBSA in 130 patients consuming nicotine or smoking compared to
4% to 24.4% TBSA in 478 patients not consuming nicotine or smoking. These
results were not significant (SMD: -0.38, 95% CI: -0.81, 0.04, I2 = 41%, p =
0.08).17, 27

INTRODUCTION
This new systematic review and meta-analysis compared outcomes and
complications between nicotine/smoking use in burn patients admitted to the
hospital to burn patients admitted without these characteristics. This review is
an attempt to compile information to create a uniform set of data for clinical
interpretation in diverse populations. Based on peer-reviewed literature, it was
hypothesized that nicotine/smoking would increase the risks of poor outcomes
and complications in patients admitted to the hospital following a burn related
injury, compared to burn patients admitted without any of these
characteristics.

RESULTS

CONCLUSION
Compared to patients suffering from burn-related injuries who do not use
nicotine and/or smoke, patients using nicotine/smoking were found to have a
higher rate of intubation and more wound/local skin infections.
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